Eric J. Sherman

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.439Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Updated Estimates of Patients With Oropharyngeal Cancer in the US

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.39258

Top 43%

0.439DataRank

Top 43%8 citations

Anna Lee, Jung Julie Kang, Irini Yacoub, Kaveh Zakeri, Edward Christopher Dee +13 more

Papers

Driven by 39 papers — median percentile 57. Top paper: “Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma”.

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Journal of Clinical Oncology(2024)10.1200/jco.23.01308

N/A

1.9DataRank · unranked

94 citations

Eric J. Sherman, Heiko Schöder, Rick Wray, Jay O. Boyle, Bhuvanesh Singh +37 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2007

N/A

0.965DataRank · unranked

32 citations

Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey +19 more

Intensity‐modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial

Cancer(2021)10.1002/cncr.33804

N/A

0.863DataRank · unranked

27 citations

Eric J. Sherman, Karissa Whiting, Margaret L. Ho, Ashok R. Shaha, Mona M. Sabra +11 more

Updated Estimates of Patients With Oropharyngeal Cancer in the US

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.39258

Top 43%

0.439DataRank

Top 43%8 citations

Anna Lee, Jung Julie Kang, Irini Yacoub, Kaveh Zakeri, Edward Christopher Dee +13 more

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers

Oral Oncology(2020)10.1016/j.oraloncology.2020.104641

N/A

0DataRank · unranked

29 citations

Jung Julie Kang, Ming Fan, Huili Wang, Anna Lee, Yao Yu +18 more

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.13205

N/A

0DataRank · unranked

74 citations

Sarin Kitpanit, Anna Lee, Dennis Mah, Kevin Sine, Eric J. Sherman +13 more

Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0442

N/A

0DataRank · unranked

20 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Han, Fengshen Kuo +12 more

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0224

N/A

0DataRank · unranked

13 citations

Yongxing Gong, Fengshen Kuo, Vladimir Makarov, Ed Reznik, Gouri J. Nanjangud +10 more

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers

Endocrine Related Cancer(2021)10.1530/erc-21-0017

N/A

0DataRank · unranked

18 citations

Jennifer R. Cracchiolo, Gnana P. Krishnamoorthy, Luis J. Leandro‐García, James Nagarajah, Mahesh Saqcena +11 more

The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6019

N/A

0DataRank · unranked

14 citations

Eric J. Sherman, Heiko Schöder, Sean M. McBride, Yao Yu, Jung Julie Kang +15 more

Randomized phase II study of sorafenib with or without everolimus in patients with radioactive iodine refractory Hürthle cell thyroid cancer (HCC) (Alliance A091302/ ITOG 1706).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6076

N/A

0DataRank · unranked

13 citations

Nathan R. Foster, Yungpo Bernard Su, Ardaman Shergill, Alan L. Ho, Bhavana Konda +4 more

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nature Communications(2022)10.1038/s41467-022-28848-x

N/A

0DataRank · unranked

114 citations

Helen Won, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong +27 more

Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer

The Laryngoscope(2022)10.1002/lary.30279

N/A

0DataRank · unranked

7 citations

Nader Mohamed, A. Rybkin, Jung Julie Kang, Megan Fiasconaro, Zhang Zhigang +10 more

Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6089

N/A

0DataRank · unranked

10 citations

R. Michael Tuttle, Ravinder K. Grewal, Eric J. Sherman, Shrujal S. Baxi, Laura Boucai +14 more

RET-Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity

Cancers(2023)10.3390/cancers15164146

N/A

0DataRank · unranked

43 citations

Matteo Repetto, Soo‐Ryum Yang, Eric J. Sherman, Alexander Drilon, Antoine Desîlets

Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment

OncoImmunology(2023)10.1080/2162402x.2023.2230666

N/A

0DataRank · unranked

2 citations

Nancy Y. Lee, Reith Sarkar, Nora Katabi, Yanyun Li, Luc G.T. Morris +6 more

Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity

Oral Oncology(2023)10.1016/j.oraloncology.2023.106400

N/A

0DataRank · unranked

7 citations

Heiko Schöder, Kaveh Zakeri, Linda Chen, Jung Julie Kang, Sean M. McBride +16 more

Data from Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck

(2023)10.1158/1078-0432.c.6517641

N/A

0DataRank · unranked

0 citations

Laurie A. Loevner, Harry Quon, Eric J. Sherman, Gregory S. Weinstein, Alex Kilger +2 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106861

N/A

0DataRank · unranked

8 citations

David G. Pfister, Sarah Stein, Winston Wong, Eric J. Sherman, James Fetten +6 more

Detection of SEZ6, a Therapeutic Target, in Medullary Thyroid Carcinoma

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae672

N/A

0DataRank · unranked

4 citations

Marina K. Baine, Achim A. Jungbluth, Anas Alabkaa, Rene Serrette, Dibisha Roy +8 more

Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer

Clinical and Translational Radiation Oncology(2024)10.1016/j.ctro.2024.100725

N/A

0DataRank · unranked

3 citations

Yao Yu, Eric J. Sherman, Richard J. Wong, Loren K. Mell, Nancy Y. Lee +2 more

An Analysis of Positron Emission Tomography Maximum Standard Uptake Value Among Patients With Head and Neck Cancer Receiving Photon and Proton Radiation

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.03.011

N/A

0DataRank · unranked

3 citations

Nader Mohamed, Daniel Kallini, Kaveh Zakeri, Haibo Lin, Dong Han +11 more

Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.10.017

N/A

0DataRank · unranked

2 citations

Bill H. Diplas, Ramesh Paudyal, Jung Hun Oh, Amaresha Konar Shridhar, Eric Aliotta +13 more

Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16‐Negative Oropharyngeal Cancers

Head & Neck(2025)10.1002/hed.28217

N/A

0DataRank · unranked

3 citations

Steven D. Wren, Trisha Shang, Yao Yu, Linda Chen, A. Shamseddine +10 more

Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure

Head & Neck(2025)10.1002/hed.70078

N/A

0DataRank · unranked

1 citations

Teeradon Treechairusame, Nadeem Riaz, Sean M. McBride, Daphna Y. Gelblum, A. Shamseddine +10 more

Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.27.635086

N/A

0DataRank · unranked

2 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.6103

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Anuja Kriplani, James Fetten, Loren S. Michel, Michael Hwang +6 more

Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers

Journal of Clinical Investigation(2025)10.1172/jci191781

N/A

0DataRank · unranked

0 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology(2025)10.1016/j.oraloncology.2025.107524

N/A

0DataRank · unranked

0 citations

Alan L. Ho, Loren S. Michel, Winston Wong, Juliana Eng, Iris Zhi +9 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102472

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Nadeem Riaz, Sean M. McBride, Yao Yu, A. Shamseddine +4 more

Pan-Cancer Efficacy of Vemurafenib in BRAF V600-Mutant Non-Melanoma Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1265

N/A

0DataRank · unranked

126 citations

Igor Puzanov, Jean‐Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje +11 more

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies

Cancer(2020)10.1002/cncr.32776

N/A

0DataRank · unranked

54 citations

Jung Julie Kang, Anna Lee, Dan Fan, Huili Wang, Sarin Kitpanit +16 more

Prognostic significance of human papillomavirus and Epstein‐Bar virus in nasopharyngeal carcinoma

Head & Neck(2020)10.1002/hed.26245

N/A

0DataRank · unranked

18 citations

Suchit H. Patel, Virginia Osborn, Sean M. McBride, Nadeem Riaz, Anna Lee +5 more

Past, present and future of proton therapy for head and neck cancer

Oral Oncology(2020)10.1016/j.oraloncology.2020.104879

N/A

0DataRank · unranked

45 citations

Anna Lee, Marc A. Cohen, Eric J. Sherman, Nancy Y. Lee, Xingzhe Li

Eric J. Sherman

Indexed papers

Top data-sharing exemplar

Papers